{"id":"61291462764-77","name":"SANOFI","registrationDate":"2009-12-11T10:53:11.112+02:00","category":2,"subCategory":3,"legal":"Public limited company","web":"http://www.sanofi.com","country":"France","headAddress":"SANOFI GROUPE","headCity":"Paris","headPostCode":"75008","headPhone":"(33)1 53 77 40 00","boss":"Olivier BRANDICOURT","bossTitle":"Mr","bossPosition":"Chief Executive Officer","membersCount":11,"membersFTE":"3.75","membership":"Professional associations:&#xd;\nAESGP - Association of the European Self-Medication Industry&#xd;\nAFEP (French Association of Private Companies) &#xd;\nEBE &#xd;\nEFPIA - European Federation of Pharmaceutical &#xd;\nIndustries Associations - and its specialized groups - EBE and Vaccines Europe &#xd;\nEuropabio&#xd;\nVaccines Europe&#xd;\n&#xd;\nThink tanks :&#xd;\nAECA&#xd;\nBruegel&#xd;\nCercle des délégués permanents&#xd;\nEPC&#xd;\nFriends of Europe &#xd;\nScience Business&#xd;\n&#xd;\nConsulting:&#xd;\nAcies&#xd;\nFipra&#xd;\nHimss Europe&#xd;\nICPS &#xd;\nSerfan","memberOrga":"For its 2018 update, Sanofi has decided to use a single entry principle for its registration. Thus, facts and figures include its following entities: Sanofi, Genzyme and Sanofi -Pasteur.","goal":"Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.&#xd;<br />&#xd;<br />With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.&#xd;<br />&#xd;<br />Sanofi, Empowering Life.","acronym":"","interests":"Competition, Consumer Affairs, Customs, Development, Economic and Financial Affairs, Employment and Social Affairs, Enlargement, Enterprise, Environment, External Relations, General and Institutional Affairs, Home Affairs, Humanitarian Aid, Information Society, Internal Market, Justice and Fundamental Rights, Public Health, Research and Technology, Taxation, Trade","euInitiatives":"(alphabetic order) &#xd;<br />Antimicrobial Microbial Resistance Action Plan,&#xd;<br />Digital in Healthcare, &#xd;<br />EU Competitiveness and Industrial policy, &#xd;<br />EU Research policy / framework program,&#xd;<br />EU Options for improving access to medicines, &#xd;<br />Health Technology Assessment Regulation,&#xd;<br />Innovative Medicines Initiative (IMI),&#xd;<br />Medical Devices Regulation,&#xd;<br />Paediatric Regulation, &#xd;<br />Personal data Regulation, &#xd;<br />Pharmaceuticals in the environment,&#xd;<br />Protection of animals used for scientific purposes &#xd;<br />Directive,&#xd;<br />Rares diseases Regulation, &#xd;<br />Reach,&#xd;<br />The Single Market Strategy, &#xd;<br />Trade Agreement,&#xd;<br />Vaccines EU policies","lastUp":"2018-04-10T09:30:13.426+02:00","customers":"","costAbsolu":"","costRange":"1000000-1249999","turnoverAbsolu":0,"turnoverRange":""}